Portacaval shunt

A portacaval shunt (or portal caval shunt) is a treatment for portal hypertension. A connection is made between the portal vein, which supplies 75% of the liver's blood, and the inferior vena cava, the vein that drains blood from the lower two-thirds of the body. The most common causes of liver disease resulting in portal hypertension are Budd–Chiari Syndrome or Cirrhosis. Budd–Chiari should not be mistaken for Cirrhosis.

Less common causes include diseases such as hemochromatosis, primary biliary cirrhosis (PBC), and portal vein thrombosis.

Cirrhotic patients often develop hepatic encephalopathy (HE) following the procedure,[1] sometimes resulting in coma.[2] The high risk of developing HE may be a consequence of increased intestinal absorption of encephalopathogenic substances in combination with the reduced hepatic blood flow.[1]

See also

References
  1. Iwatsuki S (September 1974). "A case of hepatic encephalopathy after portacaval shunt". The Japanese journal of surgery. 4 (3): 183–188. doi:10.1007/bf02468624.
  2. Sarfeh IJ, Rypins EB (April 1994). "Partial versus total portacaval shunt in alcoholic cirrhosis. Results of a prospective, randomized clinical trial". Annals of Surgery. 219 (4): 353–61. doi:10.1097/00000658-199404000-00005. PMC 1243151. PMID 8161260.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.